| PharmaSUG |
2026 |
ADaM Pet Peeves Part 2: More Things Programmers Do That Make Us Crazy |
Sandra Minjoe, Nancy Brucken, Alyssa Wittle, Nate Freimark, Richann J. Watson, Paul K. Slagle, Tatiana Sotingco |
source |
15 |
| PHUSE EU |
2025 |
RECISTance Is Useless, A Novel Visualisation Of RECIST Data Using Bubbles, On A Time-line |
Daniel Lindenbaum |
source presentation source |
10 |
| PharmaSUG |
2025 |
Roadmap to Efficacy Analysis for Early Phase Oncology studies |
Dhruv Bansal, Christiana Hawn, Chris Kelly |
source |
23 |
| PHUSE EU |
2024 |
The Challenges of Using Parent Study Data in a Long-Term Extension Study |
Kirsty Wall |
source presentation source |
9 |
| PharmaSUG |
2024 |
Submitting Patient-Reported Outcome Data in Cancer Clinical Trials - Guidance for Industry Technical Specifications Document [presentation] |
Flora Mulkey |
source |
48 |
| PHUSE US |
2024 |
Accelerating Clinical Trial Submissions with Graph Theory and Log Analysis [presentation] |
Henning Kuich, Tomás Sabat Stofsel |
source |
42 |
| PHUSE US |
2024 |
EOSS_MMRM V1.0: A Shiny Application for Estimand-Oriented Sample Size and Power Simulation Using MMRM Modelling |
Xiaoli Kong, Jing Dai |
source presentation source |
8 |
| SESUG |
2023 |
SAS Macro for Randomization-Based Methods for Covariance and Stratified Adjustment of Win Ratios and Win Odds for Ordinal Outcomes |
Elaine Kowalewski, Ann Marie K. Weideman, Gary G. Koch |
source |
11 |
| PharmaSUG |
2023 |
The Phantom of the ADaM: adding missing records to BDS datasets |
Anastasiia Drach |
source |
10 |
| PHUSE US |
2023 |
Data Handling of CTCAE Toxicity Grade Made Easier - A Metadata-driven Approach by SAS Macro [presentation] |
Zhaoyu Xie, Pragathi Mudundi |
source |
18 |
| PHUSE US |
2023 |
How Python or R Support/Facilitate the Validation Process of TFLs for a Study Development Using Hybrid SAS and R [presentation] |
Linshan Yuan, Weiwei Xu |
source |
19 |
| PHUSE US |
2023 |
SPECification DOCument (SPECDOC): Automating Text for Data Description, Statistical Methods, and Analysis Results for Medical Communications [presentation] |
Michael Pannucci |
source |
20 |
| PharmaSUG |
2020 |
Oncology Graphs-Creation (Using SAS and R), Interpretation and QA |
Taniya Muliyil |
source |
10 |
| PharmaSUG |
2019 |
From Lesion size to Best Response - Implementing RECIST through programming |
Ankit Pathak |
source |
12 |
| PharmaSUG |
2019 |
Implementing Laboratory Toxicity Grading for CTCAE Version 5 |
Keith Shusterman, Mario Widel |
source |
11 |
| PharmaSUG |
2019 |
Making Lab Toxicity Tables Less Toxic on Your Brain |
Lindsey Xie, Jinlin Wang, Jennifer Sun, Rita Lai, Richann J. Watson |
source |
13 |
| PharmaSUG |
2019 |
The Anatomy of Clinical Trials Data: A Beginner's Guide |
Venky Chakravarthy |
source |
14 |
| PHUSE US |
2019 |
A Future 'View' of Digital Data from Wearable Devices |
Daniel Schramek |
source presentation source |
11 |
| PHUSE EU |
2018 |
Step-by-step Guide to Efficacy Analysis in Solid Tumors Oncology Clinical Trials |
Anastasiia Tiurdo |
source presentation source |
11 |
| PHUSE EU |
2018 |
The Oncology-specific Domains TU, TS and RS: What to Know as a Statistical Analyst |
Frieder Wolff, Vitali Gering |
source presentation source |
8 |
| SGF |
2018 |
The Anatomy of Clinical Trials Data: A Beginner's Guide |
Venky Chakravarthy |
source |
14 |
| PHUSE EU |
2017 |
Health Technology Assessment PRO Least Squares Mean Difference Programming Techniques Using SAS |
Yirong Cao, Siory Traoré |
source presentation source |
11 |
| PharmaSUG |
2016 |
Novel Programming Methods for Change from Baseline Calculations |
Mina Chen, Peter W. Eberhardt |
source |
7 |
| PharmaSUG |
2015 |
A Methodology of Laboratory Data Reporting of Potentially Clinical Significant Abnormality (PCSA) for Clinical Study Report |
Xiangchen (Bob) Cui, Min Chen |
source |
21 |
| PHUSE EU |
2014 |
FLIPFLOP the Data: To Check Sustained Timepoint Occurrences |
Rucha Landge |
source presentation source |
8 |
| PHUSE EU |
2014 |
Implementation of Oncology Specific SDTM Domains |
Jacintha Eben |
source presentation source |
8 |
| MWSUG |
2014 |
Case Study: Generating Clinical Trial Summary Plots from an ORACLE database using the SAS Macro Language |
Shannon L. Morrison |
|
8 |
| WUSS |
2014 |
Exploring Phase 1 ADaM Deriving System from SDTM |
Yiwen Li |
source |
4 |
| PHUSE EU |
2013 |
Using PROC GENMOD to Analyses Ratio to Placebo in Change of Dactylitis |
Imgard Hollweck |
source presentation source |
9 |
| PharmaSUG |
2013 |
Combining Analysis Results from Multiply Imputed Categorical Data |
Bohdana Ratitch, Ilya Lipkovich, Michael O'Kelly |
source |
19 |
| PharmaSUG |
2012 |
A Complex ADaM dataset? Three different ways to create one. |
Kevin Lee |
source |
11 |
| PharmaSUG |
2012 |
Ir-RECIST-ible |
Sanket Kale, Jeffrey Moran |
source |
4 |
| PharmaSUG |
2012 |
Pattern-Mixture Models as Linear Combinations of Least Squares Means from MMRM with Delta Method Variance Estimation |
Bohdana Ratitch, Michael O'Kelly |
source |
15 |
| PharmaSUG |
2011 |
From SAP to BDS: The Nuts and Bolts |
Nancy Brucken, Paul K. Slagle |
source |
9 |
| WUSS |
2010 |
Mix-and-Match: Mixed Models for Analyzing Binary Outcomes with Matched Samples |
Sarah Short |
source |
9 |
| WUSS |
2010 |
The Last Shall Be First: Matching Patients by Choosing the Least Popular First |
Stefanie Millar |
source |
9 |
| PHUSE EU |
2010 |
The Ultimate Integration Challenge |
Jennifer Choon-Moi Chin, Hester Schoeman |
source presentation source |
11 |
| PharmaSUG |
2010 |
From SAP to ADaM: The Nuts and Bolts |
Nancy Brucken, Paul K. Slagle |
|
9 |
| NESUG |
2009 |
LOCF: It's more than just carrying forward |
Vikash Jain, Niraj J. Pandya |
|
10 |
| PharmaSUG |
2007 |
Implementing Worst Rank Imputation Using SAS |
Qian Wang, Eric Qi |
|
10 |
| PHUSE EU |
2006 |
Standardization in Clinical Development |
Marianne Carames |
source |
7 |
| NESUG |
2006 |
It's About Time! A Primer on Time-Slotting of Data Using SAS |
Maria Y. Reiss |
|
13 |
| WUSS |
2005 |
Revisiting the Cross-Over: A Two-Period Design Using a Treatment and a Placebo |
Qian Zhang, Mable Kong |
source |
10 |
| NESUG |
2003 |
A SAS Program for Estimating Incidence Density for Cohort Studies with Multiple Follow-ups |
Jinbing Zhang, Xiaofang Yu |
|
5 |
| PharmaSUG |
2003 |
How to LOCF without RETAIN and REINITIALIZING for FIRST.PATIENT |
Venky Chakravarthy |
|
4 |
| SUGI |
2003 |
The DOW (Not that DOW!!!) and the LOCF in Clinical Trials |
Venky Chakravarthy |
source |
4 |
| PharmaSUG |
2002 |
Data Exploration in the Pharmaceutical Industry |
Andrew T. Fagan |
|
8 |
| NESUG |
2000 |
Clinical Trial Laboratory Data Management using the SAS System |
Marianne Hack |
|
5 |
| SCSUG |
1994 |
Two Macros for Calculating Often Used Statistics of Symmetry and Agreement in the Biopharmaceutical Industry |
Jeff Heckathorn, Mark F. Munsell |
|
12 |
| SUGI |
1992 |
The Parke-Davis Assessment Program - An Example Using SQL in SAS Programming |
Russell Newhouse |
source |
6 |
| SUGI |
1990 |
The Analysis of Data from 2 X 2 Crossover Trials with Baseline Measurements |
Joe DiGennaro, William C. Huster |
source |
6 |
| SUGI |
1989 |
Multivariate Models for the Analysis of Crossover Experiments |
Vernon M. Chinchilli, Ronald K. Elswick |
source |
5 |